Related Experiment Videos
Accessible plasma exchange using membrane filter - a successfully treated case of TTP with repeated plasma exchanges
Artificial Organs
|August 1, 1981
Summary
This study shows that hollow-fiber plasma exchange is a safe and effective procedure for various diseases. It successfully replaced patient albumin and was well-tolerated, with a notable case of thrombotic thrombocytopenic purpura treated.
Area of Science:
- Nephrology
- Hematology
- Immunology
Background:
- Plasma exchange is a therapeutic apheresis technique used to remove harmful substances from the blood.
- Hollow-fiber membrane technology offers a potentially efficient method for plasma separation.
Observation:
- Plasma exchanges were performed using a hollow-fiber plasma filter in patients with diverse medical conditions.
- The procedure involved removing approximately 2 liters of plasma and replacing it with fresh frozen plasma over 1.5 to 2 hours.
- The process demonstrated a significant replacement of patient albumin, reaching up to 66% in one instance.
Findings:
- Fifty-four plasma exchange procedures were safely conducted on seven patients with minimal adverse effects like muscle cramps or itching.
- The hollow-fiber plasma filter system was easily assembled and managed by dialysis personnel.
- A successful treatment of thrombotic thrombocytopenic purpura (TTP) using this method combined with conventional therapy was documented.
Implications:
- Hollow-fiber plasma exchange is a viable and safe therapeutic option for various hematological and immunological disorders.
- This apheresis technique can effectively manage conditions like TTP and facilitate albumin replacement.
- Further research into membrane plasma exchange could optimize treatment protocols for a wider range of diseases.